Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €53.48 EUR
Change Today +0.17 / 0.32%
Volume 639.6K
As of 11:35 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

koninklijke dsm nv (DSM) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/18/15 - €54.46
52 Week Low
01/16/15 - €42.40
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for KONINKLIJKE DSM NV (DSM)

Related News

No related news articles were found.

koninklijke dsm nv (DSM) Related Businessweek News

View More BusinessWeek News

koninklijke dsm nv (DSM) Details

Koninklijke DSM N.V. operates as a life sciences and materials sciences company worldwide. The company operates through Nutrition, Performance Materials, Polymer Intermediates, and Innovation Center segments. It manufactures food enzymes, cultures, yeast extracts, savory ingredients, and other specialty ingredients for the food and beverage industries; and nutritional products, such as vitamins, carotenoids, eubiotics, feed enzymes, premixes, minerals, and nutritional lipids, as well as active and performance ingredients for the feed, food, pharmaceutical, and personal care industries. The company also offers Dyneema, a strong fiber; specialty plastics that are used in components for the electrical and electronic, automotive, flexible food packaging, and consumer goods industries; and resins solutions for paints and coatings, composite materials, and fiber optic coatings. In addition, it produces fiber intermediates, such as caprolactam, which is used as raw material for polyamide 6; acrylonitrile that is used as a raw material for acrylic fibers, plastics, rubber, water treatment chemicals, and various specialty products; and other products, including ammonium sulfate, sodium cyanide, cyclohexanone, diaminobutane, pyrrolidine, and acetonitrile. Further, the company provides bio-based chemicals and materials; KhepriCoat, which enables glass to transmit light for use in solar energy and lighting industries, as well as in horticultural and agricultural greenhouses; and develops and produces materials, as well as components, sub-assemblies, and medical devices for its customers. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands.

20,868 Employees
Last Reported Date: 04/29/15
Founded in 1902

koninklijke dsm nv (DSM) Top Compensated Officers

Chairman of the Managing Board and Chief Exec...
Total Annual Compensation: €1.2M
Chief Financial Officer and Member of the Man...
Total Annual Compensation: €630.0K
Member of the Managing Board
Total Annual Compensation: €754.0K
Member of the Managing Board
Total Annual Compensation: €724.0K
Member of the Managing Board
Total Annual Compensation: €724.0K
Compensation as of Fiscal Year 2014.

koninklijke dsm nv (DSM) Key Developments

DSM N.V. Declares Final Dividend for the Financial Year 2014, Payable on

DSM N.V. announced that the Annual General Meeting of Shareholders on 30 April 2015 passed a resolution to declare a dividend for the financial year 2014 of EUR 1.65 per ordinary share of EUR 1.50 par value. An interim dividend of EUR 0.55 per ordinary share having been paid in August 2014, the final dividend for the financial year 2014 will amount to EUR 1.10 per ordinary share. This final dividend of EUR 1.10 will be paid out in cash or in the form of ordinary shares at the option of the shareholder. Dividend in cash will be paid after deduction of 15% Dutch dividend withholding tax. The ex-dividend date on Euronext Amsterdam will be 5 May 2015 and the record date will be 6 May 2015.

DSM Announces Earnings Results for the First Quarter of 2015

DSM announced earnings results for the first quarter of 2015. For the quarter, the company posted net loss of EUR 70 million despite an 11% jump in sales, boosted by higher animal nutrition volumes and favourable exchange rates. Net profit excluding exceptional items slumped to EUR 69 million, down 24% year-on-year. Sales jumped by 11% to EUR 1.88 billion including a windfall from favourable exchange rates. Group earnings before interest, tax, depreciation and amortization also rose 4% to EUR 248 million.

DSM Reports Earnings Results for the First Quarter of 2015; Reports Impairment Charges for the First Quarter of 2015; Revises Earnings Guidance for the Year 2015

DSM reported earnings results for the first quarter of 2015. For the quarter, the company reported sales of EUR 1,886,000,000, which is an 11% increase versus last year, of which 2% was organic. EBITDA increased 4% to EUR 248 million. The increase in EBITDA was driven by Performance Materials, where there's 21% increase, resulting from positive foreign exchange effects and lower material costs. Cash from operating activities amounted to EUR 22 million for the total of DSM and EUR 84 million from continuing operations, which represents a clear improvement versus last year. Net debt increased by EUR 512 million for the quarter, mainly driven as well by foreign exchange, including mark-to-market changes and the fair value of derivative instruments held and the investments in the Aland acquisition of EUR 75 million. For the quarter, the company reported impairment of EUR 130 million. In February 2015, the company indicated that it aims to deliver an EBITDA slightly ahead of 2014. Since then, volatility in currencies continued, including a strengthening of the USD against the euro and ongoing fluctuations in the Swiss franc. The company now estimates that this could lead to an overall positive impact of approximately EUR 45 million on 2015 EBITDA should these rates persists. Therefore, taking this into account, outlook has been slightly amended to DSM aims to deliver an EBITDA in 2015 ahead of 2014, mainly driven by positive foreign exchange effects.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DSM:NA €53.48 EUR +0.17

DSM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Celanese Corp $67.85 USD -0.25
Eastman Chemical Co $78.06 USD -0.07
Grupo Bimbo SAB de CV $41.76 MXN -0.16
Johnson Matthey PLC 3,475 GBp +19.00
Solvay SA €127.90 EUR -0.15
View Industry Companies

Industry Analysis


Industry Average

Valuation DSM Industry Range
Price/Earnings 73.6x
Price/Sales 1.0x
Price/Book 1.6x
Price/Cash Flow 1,992.3x
TEV/Sales 0.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KONINKLIJKE DSM NV, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at